Atebrioz Becomes Third FDA-Approved Drug for Rare FOP, Offering a Daily Pill for Patients 12 and Older
The FDA approved Atebrioz, a daily pill for FOP in patients 12 and older. Here is what the trial showed, the fetal risk, and what it did not measure.
Medical Daily ·